Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages) View the PDF document
Table of Contents
Close this folderExecutive summary
View the documentBackground
View the documentDrug financing issues
View the documentCost-sharing for drugs
View the documentMonitoring for equity and quality
View the documentConclusions and recommendations
View the documentWorkshop evaluation
Open this folder and view contents1. Introduction
Open this folder and view contents2. Country presentations on drug financing
Open this folder and view contents3. Korat provincial field visit
Open this folder and view contents4. Drug financing issues
Open this folder and view contents5. Country priorities for drug financing
Open this folder and view contents6. Priorities for work group action
Open this folder and view contents7. Conclusions and recommendations
View the documentAnnex A. Agenda
View the documentAnnex B. List of participants
View the documentAnnex C. List of documents
View the documentAnnex D. Message from Regional Director, WHO South-East Asia Region
Open this folder and view contentsAnnex E. Evaluation of the meeting. Priorities for the Working Group
 

Workshop evaluation

An evaluation of the different aspects of the workshop was made. Participants identified topics based on the prevailing needs of the countries. The topics which could be taken up at the next meeting of the Working Group are in order of priority: public financing, including drug financing indicators and ways to increase public drug budgets; policies and guidelines for cost-sharing; public-private roles in the pharmaceutical sector; and financing mechanisms to improve rational use of drugs.

The next meeting will be held in Yogyakarta, Indonesia in November 1997.

 

to previous section to next section
 

Last updated: May 3, 2013